Expertise in
26
conditions

Dr. Marc A. Dallera

Urology
Gynecologic Oncology Surgery UC Davis Comprehensive Cancer Center
2279 45th St, 
Sacramento, CA 
Offers Telehealth
Expertise in
26
conditions
Gynecologic Oncology Surgery UC Davis Comprehensive Cancer Center
2279 45th St, 
Sacramento, CA 

Overview

Marc Dallera is a Urologist practicing medicine in Sacramento, California.

Dr. Dallera is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Prostate Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Cystectomy.

He is actively involved in clinical research, co-authoring 105 peer reviewed articles and participating in 4 clinical trials.

Specialties

Urology

Licenses

Urology in CA

Hospital Affiliations

Tahoe Forest Hospital
Marshall Medical Center
Mark Twain Medical Center
Oroville Hospital
University Of California Davis Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Moda Health
  • EPO
  • PPO
Sutter Health
  • HMO
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Western Health Advantage
  • HMO
  • INSURANCE PLAN
  • MEDICARE DISCOUNT CARD
  • MEDICARE MAPD
View 13 Less Insurance Carriers -

Locations

Gynecologic Oncology Surgery UC Davis Comprehensive Cancer Center
2279 45th St, Sacramento, CA 95817

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Phase II Trial of Intravesical Gemcitabine and MK-3475 (Pembrolizumab) in the Treatment of Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Phase II Trial of Intravesical Gemcitabine and MK-3475 (Pembrolizumab) in the Treatment of Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 11, 2026
Intervention Type: Procedure, Drug, Biological
Study Drugs: Gemcitabine Hydrochloride, Pembrolizumab
Study Phase: Phase 2
Phase II Trial of PARP Inhibitor Niraparib for Men With High Risk Prostate Cancer and DNA Damage Response Defects
Phase II Trial of PARP Inhibitor Niraparib for Men With High Risk Prostate Cancer and DNA Damage Response Defects
Enrollment Status: Terminated
Publish Date: May 14, 2026
Intervention Type: Drug, Procedure
Study Drugs: Niraparib, Niraparib Tosylate Monohydrate
Study Phase: Phase 2
A Study of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With Non-Muscle Invasive Bladder Cancer
A Study of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With Non-Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: March 31, 2026
Intervention Type: Biological
Study Drugs: Bacillus of Calmette-Guerin, ALT-803
Study Phase: Phase 1/Phase 2
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Enrollment Status: Completed
Publish Date: May 22, 2025
Intervention Type: Drug
Study Drug: Atezolizumab
Study Phase: Phase 2
View 3 Less Clinical Trials

105 Total Publications

Phase I first-in-human dose-escalation trial of a bladder cancer-specific nanoparticle in non-muscle-invasive bladder cancer.
Phase I first-in-human dose-escalation trial of a bladder cancer-specific nanoparticle in non-muscle-invasive bladder cancer.
Journal: Nanomedicine (London, England)
Published: July 08, 2026
Similar Doctors
Expertise in
15
conditions
Expertise in
15
conditions
Referral may be required

Office

4860 Y St Ste 3500, 
Sacramento, CA 
 (0.3 miles away)
916-734-2823
Languages Spoken:
English

Derya Tilki is a Urologist practicing medicine in Sacramento, California. Dr. Tilki is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Bladder Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Cystectomy.

Expertise in
31
conditions
Expertise in
31
conditions
Referral may be required

Office

1535 River Park Dr, 
Sacramento, CA 
 (3.3 miles away)
916-286-1080
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Noah Canvasser is a Urologist practicing medicine in Sacramento, California. Dr. Canvasser is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Kidney Stones, Perirenal Abscess, Boils, Ureteroscopy, and Prostatectomy.

Expertise in
12
conditions
Dr. Seshadri Kasturi
Urology | Obstetrics and Gynecology
Expertise in
12
conditions
Dr. Seshadri Kasturi
Urology | Obstetrics and Gynecology
Referral may be required
Before you request
2801 K St., Suite 200, 
Sacramento, CA 
 (1.6 miles away)
916-779-1160
Languages Spoken:
English, Hindi, Hmong, Russian, Spanish, Tamil, Telugu, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Seshadri Kasturi is a Urologist and an Obstetrics and Gynecologist practicing medicine in Sacramento, California. Dr. Kasturi is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Uterine Prolapse, Urinary Incontinence, Stress Urinary Incontinence, Rectocele, and Bladder Reconstruction. Dr. Kasturi is board certified in OB & Gyn (Sub: Female Pelvic Med/Reconstruct Surg), Female Pelvic Medicine And Reconstructive Surgery, and Obstetrics & Gynecology. Dr. Kasturi is currently accepting new patients.

Frequently Asked Questions about Dr. Marc A. Dallera

How do I make an appointment with Dr. Marc A. Dallera?

You can book an appointment with Dr. Marc A. Dallera by calling their office at 916-734-5959. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Marc A. Dallera a top-rated expert for Bladder Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Marc A. Dallera is classified as an Elite expert for Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Marc A. Dallera specialize in?

While Dr. Marc A. Dallera is a Urology, they have specific expertise in Bladder Cancer, Prostate Cancer, and Muscle Invasive Bladder Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Urology.

Does Dr. Marc A. Dallera participate in research or clinical trials?

Yes. Dr. Marc A. Dallera has published 105 articles and abstracts on conditions like Bladder Cancer. You can view a list of Dr. Marc A. Dallera's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Marc A. Dallera accept my insurance?

Dr. Marc A. Dallera accepts most major insurance plans, including Alignment Health Plan and Anthem BCBS. We recommend calling the office directly at 916-734-5959 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dallera's expertise for a condition
ConditionClose
View All 14 Distinguished Conditions
View All 9 Advanced Conditions
View All 35 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile